Literature DB >> 19868113

A NOTE ON THE PRODUCTION OF ANTIPNEUMOCOCCUS SERA.

A B Wadsworth1, M B Kirkbride.   

Abstract

Horses immunized to Type I pneumococci developed serum, 0.1 cc. of which protected against 0.5 cc. of a virulent culture, 0.000001 cc. of which killed mice in less than 40 hours. Protective tests of serum from horses immunized to Type II organisms varied, 0.1 cc. protecting, however, in certain instances against 0.1 and 0.01 cc. of virulent homologous culture. Types I and II sera obtained in our experiments with culture sediment and whole culture did not vary markedly for a given type and corresponded closely in their protective titer with samples of sera received from The Rockefeller Institute Hospital. It is therefore evident that the following minimum standard of 0.1 cc. of serum to protect mice against at least 0.2 cc. of virulent cultures can and should be maintained when serum is to be used for the treatment of cases. By further study and comparison of these different methods of immunization it is hoped that sera of greater potency may be produced, but as yet this has only been accomplished in exceptional instances. A horse immunized with Type III (Pneumococcus mucosus) developed serum having a slight degree of protection for mice against the corresponding organisms. This serum was sufficiently potent, however, to cause prompt and complete agglutination when combined with fresh untreated homologous organisms, thus avoiding the preliminary treatment to remove the capsule which has previously been held necessary. As a diagnostic aid in the differentiation of pneumococcus strains, the serum has proved of distinct value.

Entities:  

Year:  1917        PMID: 19868113      PMCID: PMC2125514          DOI: 10.1084/jem.25.5.629

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  METHODS FOR THE DETERMINATION OF PNEUMOCOCCUS TYPES.

Authors:  F G Blake
Journal:  J Exp Med       Date:  1917-07-01       Impact factor: 14.307

2.  THE BIOLOGICAL IDENTITY OF THE FRIEDLANDER BACILLUS.

Authors:  C B Coulter
Journal:  J Exp Med       Date:  1917-12-01       Impact factor: 14.307

3.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-03-31       Impact factor: 14.307

4.  THE RELATION OF THE CAPSULAR SUBSTANCE OF B. COLI TO ANTIBODY PRODUCTION.

Authors:  T Smith
Journal:  J Exp Med       Date:  1928-08-31       Impact factor: 14.307

5.  STUDIES ON IMMUNOLOGICAL RELATIONSHIPS AMONG THE PNEUMOCOCCI : II. A COMPARISON OF THE ANTIBODY RESPONSES OF MICE AND OF RABBITS TO IMMUNIZATION WITH TYPICAL TYPE III PNEUMOCOCCI AND TO IMMUNIZATION WITH A RELATED STRAIN.

Authors:  A L Harris; J Y Sugg; J M Neill
Journal:  J Exp Med       Date:  1928-05-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.